Literature DB >> 24611168

Infectious disease: Beating the big three.

Katherine Bourzac.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 24611168     DOI: 10.1038/507s4a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  Phenotypic Screens in Antimalarial Drug Discovery.

Authors:  Marisa L Hovlid; Elizabeth A Winzeler
Journal:  Trends Parasitol       Date:  2016-05-27

2.  Systemic Manifestation of Miliary Tuberculosis in Patient With Advanced Diabetic Retinopathy Presenting With Electrolyte Imbalance, Seizures, and Adrenal Insufficiency.

Authors:  Zahid Khan; Davina Jugnarain; Bashir Mahamud; Animesh Gupta; Shirin Patel; Gideon Mlawa
Journal:  Cureus       Date:  2022-01-09

3.  Rational design, preparation and characterization of recombinant Ag85B variants and their glycoconjugates with T-cell antigenic activity against Mycobacterium tuberculosis.

Authors:  Francesca Rinaldi; Sara Tengattini; Luciano Piubelli; Roberta Bernardini; Francesca Mangione; Teodora Bavaro; Gregorino Paone; Maurizio Mattei; Loredano Pollegioni; Gaetano Filice; Caterina Temporini; Marco Terreni
Journal:  RSC Adv       Date:  2018-06-26       Impact factor: 4.036

4.  In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.

Authors:  Steffen Lindert; Lorillee Tallorin; Quynh G Nguyen; Michael D Burkart; J Andrew McCammon
Journal:  J Comput Aided Mol Des       Date:  2014-10-25       Impact factor: 3.686

5.  Glycosylation of Recombinant Antigenic Proteins from Mycobacterium tuberculosis: In Silico Prediction of Protein Epitopes and Ex Vivo Biological Evaluation of New Semi-Synthetic Glycoconjugates.

Authors:  Teodora Bavaro; Sara Tengattini; Luciano Piubelli; Francesca Mangione; Roberta Bernardini; Vincenzina Monzillo; Sandra Calarota; Piero Marone; Massimo Amicosante; Loredano Pollegioni; Caterina Temporini; Marco Terreni
Journal:  Molecules       Date:  2017-06-29       Impact factor: 4.411

6.  Comparing research investment to United Kingdom institutions and published outputs for tuberculosis, HIV and malaria: a systematic analysis across 1997-2013.

Authors:  Michael G Head; Joseph R Fitchett; Gemma Derrick; Fatima B Wurie; Jonathan Meldrum; Nina Kumari; Benjamin Beattie; Christopher J Counts; Rifat Atun
Journal:  Health Res Policy Syst       Date:  2015-11-04

7.  Monitoring antigenic protein integrity during glycoconjugate vaccine synthesis using capillary electrophoresis-mass spectrometry.

Authors:  Sara Tengattini; Elena Domínguez-Vega; Caterina Temporini; Marco Terreni; Govert W Somsen
Journal:  Anal Bioanal Chem       Date:  2016-07-02       Impact factor: 4.142

8.  Quantifying Limits on Replication, Death, and Quiescence of Mycobacterium tuberculosis in Mice.

Authors:  Margaret M McDaniel; Nitin Krishna; Winode G Handagama; Shigetoshi Eda; Vitaly V Ganusov
Journal:  Front Microbiol       Date:  2016-06-14       Impact factor: 5.640

Review 9.  Traditional and syndromic surveillance of infectious diseases and pathogens.

Authors:  Cédric Abat; Hervé Chaudet; Jean-Marc Rolain; Philippe Colson; Didier Raoult
Journal:  Int J Infect Dis       Date:  2016-04-30       Impact factor: 3.623

10.  Community and topic modeling for infectious disease clinical trial recommendation.

Authors:  Magdalyn E Elkin; Xingquan Zhu
Journal:  Netw Model Anal Health Inform Bioinform       Date:  2021-07-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.